gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Akita, T; Chuon, C; E, B; Hossain, MS; Hussain, MRA; Kim, R; Ko, K; Nagashima, S; Ork, V; Ouoba, S; Saphonn, V; Sato, T; Sugiyama, A; Takahashi, K; Tanaka, J; Tung, R | 1 |
| Alleman, MM; Biey, J; Bwaka, AM; Impouma, B; Kabore, HJ; Li, X; Manzengo, CM; Mumba, M; Paluku, G; Tohme, RA | 1 |
2 other study(ies) available for gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
Topics: Cambodia; COVID-19; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Longitudinal Studies; Pregnancy; Pregnancy Complications, Infectious; Vaccination | 2023 |
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
Topics: Child, Preschool; COVID-19; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Pandemics; Seroepidemiologic Studies; World Health Organization | 2023 |